This book offers a progress report on efforts to meet the challenges faced by ovarian cancer patients and their doctors. It provides a current perspective on therapeutic developments as a partnership between laboratory-based and clinical-based researchers.
This book offers a progress report on efforts to meet the challenges faced by ovarian cancer patients and their doctors. It provides a current perspective on therapeutic developments as a partnership between laboratory-based and clinical-based researchers.
Artikelnr. des Verlages: 12566617, 978-1-4419-7215-6
2011
Seitenzahl: 308
Erscheinungstermin: 24. November 2010
Englisch
Abmessung: 241mm x 160mm x 22mm
Gewicht: 553g
ISBN-13: 9781441972156
ISBN-10: 1441972153
Artikelnr.: 30643503
Autorenporträt
Robert Brown, geboren 1957, ist seit über 25 Jahren eines der bekanntesten und anerkanntesten hellsichtigen Medien aus England. Seine besonderen Fähigkeiten wurden bereits als Kind erkannt. Robert Brown, hält weltweit Vorträge, Seminare, Demonstrationen und Einzelberatungen.
Inhaltsangabe
1 Existing treatment for ovarian cancer: recent advances and description of unmet needs S Banerjee M Bookman M Gore 2 Discovery of novel targets J Farley M Birrer 3 Anti-angiogenesis - update on its application in ovarian cancer J Hasan G Jayson 4 Targeting the PI3K/AKT pathway E Stronach A Cheraghchi-Bashi M Chen H Gabra 5 Inhibition of the SRC oncogene; potential in ovarian cancer LY Han AK Sood 6 Tumour specific synthetic lethality; targeting BRCA gene dysfunction TA Yap SB Kaye A Ashworth A Tutt 7 Inhibition of cytokines and chemokines in ovarian cancer J Coward F Balkwill 8 Potential for inhibition of membrane receptors (EGF, IGF, c-MET, and others) LP Martin JJ Perkins R Schilder 9 An epigenetic approach to ovarian cancer R Brown N Chapman-Rothe R Glasspool 10 Immunotherapy; update on its application in ovarian cancer S Ghaem-Maghami M Gore 11 Ovarian cancer progenitor/stem cells; therapeutic potential S Murphy A Berchuck 12 Potential for a-folate receptor targeted treatment for ovarian cancer CHM Ng A Jackman 13 New insights into tubulin binders J Brenton
1 Existing treatment for ovarian cancer: recent advances and description of unmet needs S Banerjee M Bookman M Gore 2 Discovery of novel targets J Farley M Birrer 3 Anti-angiogenesis - update on its application in ovarian cancer J Hasan G Jayson 4 Targeting the PI3K/AKT pathway E Stronach A Cheraghchi-Bashi M Chen H Gabra 5 Inhibition of the SRC oncogene; potential in ovarian cancer LY Han AK Sood 6 Tumour specific synthetic lethality; targeting BRCA gene dysfunction TA Yap SB Kaye A Ashworth A Tutt 7 Inhibition of cytokines and chemokines in ovarian cancer J Coward F Balkwill 8 Potential for inhibition of membrane receptors (EGF, IGF, c-MET, and others) LP Martin JJ Perkins R Schilder 9 An epigenetic approach to ovarian cancer R Brown N Chapman-Rothe R Glasspool 10 Immunotherapy; update on its application in ovarian cancer S Ghaem-Maghami M Gore 11 Ovarian cancer progenitor/stem cells; therapeutic potential S Murphy A Berchuck 12 Potential for a-folate receptor targeted treatment for ovarian cancer CHM Ng A Jackman 13 New insights into tubulin binders J Brenton
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497